UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001379
Receipt number R000001677
Scientific Title Prospective randomized controlled study for the therapeutic effect of removing uremic toxins on endothelial function in undialyzed patients with chronic renal failure
Date of disclosure of the study information 2008/10/01
Last modified on 2011/03/17 12:53:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective randomized controlled study for the therapeutic effect of removing uremic toxins on endothelial function in undialyzed patients with chronic renal failure

Acronym

Effect of removing uremic toxins on endothelial function

Scientific Title

Prospective randomized controlled study for the therapeutic effect of removing uremic toxins on endothelial function in undialyzed patients with chronic renal failure

Scientific Title:Acronym

Effect of removing uremic toxins on endothelial function

Region

Japan


Condition

Condition

Undialyzed patients with chronic renal failure

Classification by specialty

Medicine in general Cardiology Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the therapeutic effect of removing uremic toxins by oral adsorbent AST-120 on endothelial function in undialyzed patients with chronic renal failure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Flow-mediated vasodilation of branchial artery

Key secondary outcomes

Changes of the below parameters:
(1) Systolic and diastolic blood pressure
(2) Creatinine clearance (Ccr)
(3) Urinary protein excretion (UPE)
(4) Mediators associated with endothelial function


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Treated by AST-120 6g daily for a period of 6 months

Interventions/Control_2

Not treated by AST-120 for a period of 6 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Medications have not been changed in the last 6 months.
(2) Blood pressures have been controlled appropriately in the last 6 months.
(3) HbA1c levels have been stable within +/-0.5% changes in the last 6 months.
(4) Over 20 years of age.
(5) Patients with the informed consent to this study.

Key exclusion criteria

(1) Patients with obstructive or stenotic diseases of digestive organs.
(2) Patients with the nephrotic syndrome.
(3) Patients with acute renal failure, rapid elevation of serum creatinine or active nephropahty in the last 6 months.
(4) Patients with inflammatory or consumptive diseases (e.g. infection, malignancy).
(5) Patients with severe cardiovascular diseases (e.g. heart failure, coronary disease, cerebrovascular disease, peripheral vascular disease).
(6) Dialyzed patients.
(7) Patients treated by AST-120.
(8) Patients treated by steroids or immunosuppressive agents.
(9) Females in pregnancy.
(10) Patients judged as unsuitable for participating in this study by the attending physician.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Norio Komai

Organization

Kawasaki Medical School

Division name

Division of Nephrology, Department of Internal Medicine

Zip code


Address

577 Matsushima, Kurashiki, Okayama 701-0192

TEL

086-462-1111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yuko Nishi

Organization

Kawasaki Medical School

Division name

Division of Nephrology, Department of Internal Medicine

Zip code


Address

577 Matsushima, Kurashiki, Okayama 701-0192

TEL

086-462-1111

Homepage URL


Email

yuko-n77@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Division of Nephrology, Department of Internal Medicine, Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

None


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 09 Month 08 Day

Date of IRB


Anticipated trial start date

2009 Year 01 Month 01 Day

Last follow-up date

2011 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 09 Month 17 Day

Last modified on

2011 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001677